 |
News releases
Please be advised that the information posted was accurate at the time of posting, but may be superseded by subsequent news releases.
To automatically receive future news releases, please go to the News
subscription service page.
2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- [2003]
- 2002
(click to view the full text)
|
May 29, 2003
Æterna Laboratories holds Annual Meeting |
June 2, 2003
Æterna Presents Status on Neovastat Phase III Trials in Kidney Cancer and Lung Cancer |
July 7, 2003
Æterna enters into agreement for a $35.6 million bought deal |
July 24, 2003
Æterna closes $35.6 million bought deal |
August 6, 2003
Æterna Laboratories Reports Second Quarter Results |
September 16, 2003
Æterna Laboratories to Present at Healthcare Conferences |
August 5, 2003
Æterna Laboratories Announces Results Conference Call and Webcast |
October 29, 2003
Æterna Laboratories Announces Quarterly Financial Release, Conference Call and Webcast |
September 24, 2003
Æterna Laboratories Reports Phase III Trial Results in Renal Cell Carcinoma with Neovastat |
October 2, 2003
Æterna receives Deloitte & Touche Canadian Technology Fast 50 award and ranked 18th |
November 26, 2003
Æterna Subsidiary Atrium Acquires Another Company |
November 19, 2003
Appointments to Æterna’s Board of Directors |
November 10, 2003
Æterna Laboratories Inc. to Present at CIBC Conference |
November 5, 2003
Æterna Laboratories Reports Third Quarter Results |
March 26, 2003
Æterna signs an agreement with LG Life Sciences for marketing Neovastat in Korea |
June 18, 2003
Æterna Extends Successful Collaboration with Serono on Cetrotide® |
July 29, 2003
Æterna reports positive Phase III trial results with Impavido® (miltefosine) |
January 28, 2003
Appointments to Æterna Management and Board of Directors |
January 13, 2003
Æterna Reports on its New Product Pipeline and Clinical Development Strategy Following Zentaris Acquisition |
January 8, 2003
Æterna-subsidiary Zentaris AG Signs Product Partnership for Novel Platinum Cancer Drug in China |
January 8, 2003
Æterna Laboratories Conference Call on Acquisition of Zentaris AG -Monday, January 13, 2003 at 11 a.m. EST |
February 27, 2003
Æterna’s Subsidiary, Zentaris, to start distribution of Impavido® in India |
February 20, 2003
Æterna Reports Financial Results for 2002 |
February 14, 2003
Æterna Receives Milestone Payment from Baxter |
December 17, 2003
Æterna updates Neovastat’s clinical development plan |
April 30, 2003
Æterna Laboratories Reports First Quarter Results |
April 25, 2003
Æterna Laboratories Announces Quarterly Financial Release, Conference Call and Webcast |
April 23, 2003
Æterna discloses new scientific data on Neovastat |
April 8, 2003
Appointments to Æterna Scientific Advisory Board |
April 1, 2003
Æterna enters into a $25 million convertible term loan and completes the integration of Zentaris AG |
 |
 |
